In the current study, we also observed a significant elevation of TBARS levels in the control and RB groups, which indicate severe tissue damage in the RB group (p > 0.05 vs. control), but not in the FRB group (p < 0.05 vs. control). The gene discussed is FOLR2; the disease is retinoblastoma.